AMERICAN BIO MEDICA CORPORATION — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/1a4f23b8-01a4-49fd-821a-f91298e0ad32/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-1.2M | 2022-01-01 – 2022-12-31 | evidence 0001654954-23-003260 |
| FY 2021 | $-1.2M | 2021-01-01 – 2021-12-31 | evidence 0001654954-22-005014 |
| FY 2020 | $-621.0k | 2020-01-01 – 2020-12-31 | evidence 0001654954-21-004250 |
| FY 2019 | $-593.0k | 2019-01-01 – 2019-12-31 | evidence 0001654954-20-007022 |
| FY 2018 | $-762.0k | 2018-01-01 – 2018-12-31 | evidence 0001654954-19-004490 |
| FY 2017 | $-311.0k | 2017-01-01 – 2017-12-31 | evidence 0001654954-18-003884 |
| FY 2016 | $-257.0k | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-018013 |
| FY 2015 | $-13.0k | 2015-01-01 – 2015-12-31 | evidence 0001144204-17-018013 |
| FY 2014 | $-217.0k | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-019717 |
| FY 2013 | $-1.1M | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-019165 |
| FY 2012 | $-929.0k | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-018226 |
| FY 2011 | $-146.0k | 2011-01-01 – 2011-12-31 | evidence 0001144204-12-021826 |
| FY 2010 | $-534.0k | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-021826 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
AMERICAN BIO MEDICA CORPORATION — all facts · Revenue · Net Income